Federal Register / Vol. 63, No. 11 / Friday, January 16, 1998 / Notices 2683

741–8138 (301–443–0572 in the

Washington, DC area), code 12532.

Please call the Information Line for upto-date information on this meeting.

Agenda: The committee will discuss

preliminary planning of a claims

structure for a future guidance for the

development of drugs, biologics, and

devices for the treatment of

osteoarthritis.

Procedure: Interested persons may

present data, information, or views,

orally or in writing, on issues pending

before the committee. Written

submissions may be made to the contact

person by February 13, 1998. Oral

presentations from the public will be

scheduled between approximately 8

a.m. and 9 a.m. Time allotted for each

presentation may be limited. Those

desiring to make formal oral

presentations should notify the contact

person before February 13, 1998, and

submit a brief statement of the general

nature of the evidence or arguments

they wish to present, the names and

addresses of proposed participants, and

an indication of the approximate time

requested to make their presentation.

Notice of this meeting is given under

the Federal Advisory Committee Act (5

U.S.C. app. 2).

Dated: January 9. 1998.

Michael A. Friedman,

Deputy Commissioner for Operations.

[FR Doc. 98–1083 Filed 1–15–98; 8:45 am]

BILLING CODE 4160–01–F

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute on Drug Abuse;

Notice of Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

National Advisory Council on Drug

Abuse, National Institute on Drug Abuse

(NIDA) on February 3–4, 1998, at the

Bethesda Marriott Hotel, 5151 Pooks

Hill Road, Bethesda, MD 20814.

On February 3, from 9 a.m. to 4 p.m.,

in accordance with provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. and sec. 10(d) of Pub. L. 92–

463, this portion of the meeting will be

closed to the public for the review,

discussion, and evaluation of grant

applications. These applications and the

discussions could reveal confidential

trade secrets or commercial property

such as patentable material and

personal information concerning

individuals associated with the

applications, disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

On February 4, from 9 a.m. to 5 p.m.,

this portion of the meeting will be open

to the public for announcements and

reports of administrative, legislative,

and program developments in the drug

abuse field. Attendance by the public

will be limited to space available.

A summary of the meeting and a

roster of committee members may be

obtained from Ms. Camilla L. Holland,

NIDA Committee Management Officer,

National Institutes of Health, Parklawn

Building, Room 10–42, 5600 Fishers

Lane, Rockville, MD 20857, (301/443–

2755).

Substantive program information may

be obtained from Dr. Teresa Levitin,

Room 10–42, Parklawn Building, 5600

Fishers Lane, Rockville MD 20857, (301/

443–2755).

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact Dr. Levitin in advance of the

meeting.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.277, Drug Abuse

Research Scientist Development and

Research Scientist Awards; 93.278, Drug

Abuse National Research Service Awards for

Research Training; 93.279, Drug Abuse

Research Programs)

Dated: January 8, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–1121 Filed 1–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review; Notice of

Closed Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Center

for Scientific Review Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review individual

grant applications.

Name of SEP: Behavioral and

Neurosciences.

Date: January 20, 1998.

Time: 11:00 a.m.

Place: NIH, Rockledge 2, Room 5060;

Telephone Conference.

Contact Person: Dr. Samuel Rawlings,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5060, Bethesda, MD

20892, (301) 435–1243.

Name of SEP: Biological and Physiological

Sciences.

Date: January 20, 1998.

Time: 3:00 p.m.

Place: NIH, Rockledge 2, Room 4148;

Telephone Conference.

Contact Person: Dr. Philip Perkins,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4148, Bethesda, MD

20892, (301) 435–1718.

Name of SEP: Biological and Physiological.

Date: January 21, 1998.

Time: 12:00 p.m.

Place: NIH, Rockledge 2, Room 4150;

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda, MD

20892, (301) 435–1719.

Name of SEP: Biological and Physiological

Sciences.

Date: January 8, 1998.

Time: 4:00 p.m.

Place: NIH, Rockledge 2, Room 4150;

Telephone Conference.

Contact Person: Dr. Marcia Litwack,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4150, Bethesda, MD

20892, (301) 435–1719.

This notice is being published less than 15

days prior to the above meetings due to the

urgent need to meet timing limitations

imposed by the grant review and funding

cycle.

Name of SEP: Biological and Physiological

Sciences.

Date: February 22, 1998.

Time: 6:00 p.m.

Place: Hyatt Regency, Bethesda, MD.

Contact Person: Dr. Sooja Kim, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 5178, Bethesda, MD 20892, (301) 435–

1780.

Name of SEP: Biological and Physiological.

Date: February 18, 1998.

Time: 11:00 a.m.

Place: NIH, Rockledge 2, Room 9112.

Contact Person: Dr. Mushtaq Khan,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4124, Bethesda, MD

20892, (301) 435–1778.

Name of SEP: Biological and Physiological

Sciences.

Date: February 23, 1998.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 6168;

Telephone Conference.

Contact Person: Dr. Syed Amir, Scientific

Review Administrator, 6701 Rockledge Drive,

Room 6168, Bethesda, MD 20892, (301) 435–

1043.

Name of SEP: Biological and Physiological

Sciences.

Date: February 24, 1998.

Time: 2:00 p.m.

Place: NIH, Rockledge 2, Room 4172;

Telephone Conference.

Contact Person: Dr. Donald Schneider,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4172, Bethesda, MD

20892, (301) 435–1165.

Name of SEP: Multidisciplinary Sciences.

Date: March 18–20, 1998.

Time: 6:00 p.m.

Place: Radisson Hotel, Los Angeles, CA.

Contact Person: Dr. Bill Bunnag, Scientific

Review Administrator, 6701 Rockledge Drive,
2684 Federal Register / Vol. 63, No. 11 / Friday, January 16, 1998 / Notices

Room 5212, Bethesda, MD 20892, (301) 435–

1177.

The meetings will be closed in accordance

with the provisions set forth in secs. 552(c)(4)

and 552b(c)(6), Title 5, U.S.C. Applications

and/or proposals and the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material and personal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 39.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93,893, National Institutes of Health,

HHS)

Dated: January 9, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–1120 Filed 1–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

Center for Scientific Review Advisory

Committee Meeting

Pursuant to Pub. L. 92–463, notice is

hereby given of the meeting of the

Center for Scientific Review Advisory

Committee, February 17–18, 1998,

Building 31C, Conference Room 6,

National Institutes of Health, Bethesda,

MD 20892.

The entire meeting will be open to the

public from 8:30 a.m. on February 17 to

adjournment on February 18. The

meeting will include, among other

topics, a discussion of some recent

experiences and experiments in

streamlining the peer review system.

Attendance by the public will be limited

to space available.

The Office of Committee

Management, Center for Scientific

Review, Rockledge 2 Building, Suite

3016, National Institutes of Health,

Bethesda, MD 20892–7778, telephone

(301) 435–1124, will furnish a summary

of the meeting and a roster of the

committee members.

Dr. Samuel Joseloff, Executive

Secretary of the Committee, Rockledge 2

Building, Suite 3176, National Institutes

of Health, Bethesda, MD 20892–7762,

phone (301) 435–0691, will provide

substantive program information upon

request.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the Executive Secretary at least

two weeks in advance of the meeting.

Dated: January 8, 1998.

LaVerne Y. Stringfield,

Committee Management Officer, NIH.

[FR Doc. 98–1122 Filed 1–15–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HOUSING AND

URBAN DEVELOPMENT

[Docket No. FR–4235–N–38]

Federal Property Suitable as Facilities

To Assist the Homeless

AGENCY: Office of the Assistant

Secretary for Community Planning and

Development, HUD.

ACTION: Notice.

SUMMARY: This Notice identifies

unutilized, underutilized, excess, and

surplus Federal property reviewed by

HUD for suitability for possible use to

assist the homeless.

FOR FURTHER INFORMATION CONTACT:

Mark Johnston, room 7256, Department

of Housing and Urban Development,

451 Seventh Street SW, Washington, DC

20410; telephone (202) 708–1226; TDD

number for the hearing- and speechimpaired (202) 708–2565 (these

telephone numbers are not toll-free), or

call the toll-free Title V information line

at 1–800–927–7588.

SUPPLEMENTARY INFORMATION: In

accordance with 24 CFR part 581 and

section 501 of the Stewart B. McKinney

Homeless Assistance Act (42 U.S.C.

11411), as amended, HUD is publishing

this Notice to identify Federal buildings

and other real property that HUD has

reviewed for suitability for use to assist

the homeless. The properties were

reviewed using information provided to

HUD by Federal landholding agencies

regarding unutilized and underutilized

buildings and real property controlled

by such agencies or by GSA regarding

its inventory of excess or surplus

Federal property. This Notice is also

published in order to comply with the

December 12, 1998 Court Order in

National Coalition for the Homeless v.

Veterans Administration, No. 88–2503–

OG (D.C.C.).

Properties reviewed are listed in this

Notice according to the following

categories. Suitable/available, suitable/

unavailable, suitable/to be excess, and

unsuitable. The properties listed in the

three suitable categories have been

reviewed by the landholding agencies,

and each agency has transmitted to

HUD: (1) Its intention to make the

property available for use to assist the

homeless, (2) its intention to declare the

property excess to the agency’s needs, or

(3) a statement of the reasons that the

property cannot be declared excess or

made available for use as facilities to

assist the homeless.

Properties listed as suitable/available

will be available exclusively for

homeless use for a period of 60 days

from the date of this Notice. Homeless

assistance providers interested in any

such property should send a written

expression of interest to HHS, addressed

to Brian Rooney, Division of Property

Management, Program Support Center,

HHS, room 5B–41, 5600 Fishers Lane,

Rockville, MD 20857; (301) 443–2265.

(This is not a toll-free number.) HHS

will mail to the interested provider an

application packet, which will include

instructions for completing the

application. In order to maximize the

opportunity to utilize a suitable

property, providers should submit their

written expressions of interests as soon

as possible. For complete details

concerning the processing of

applications, the reader is encouraged to

refer to the interim rule governing this

program, 24 CFR part 581.

For properties listed as suitable/to be

excess, that property may, if

subsequently accepted as excess by

GSA, be made available for use by the

homeless in accordance with applicable

law, subject to screening for other

Federal use. At the appropriate time,

HUD will publish the property in a

Notice showing it as either suitable/

available or suitable/unavailable.

For properties listed as suitable/

unavailable, the landholding agency has

decided that the property cannot be

declared excess or made available for

use to assist the homeless, and the

property will not be available.

Properties listed as unsuitable will

not be made available for any other

purpose for 20 days from the date of this

Notice. Homeless assistance providers

interested in a review by HUD of the

determination of unsuitability should

call the toll free information line at 1–

800–927–7588 for detailed instructions

or write a letter to Mark Johnston at the

address listed at the beginning of this

Notice. Included in the request for

review should be the property address

(including zip code), the date of

publication in the Federal Register, the

landholding agency, and the property

number.

For more information regarding

particular properties identified in this

Notice (i.e., acreage, floor plan, existing

sanitary facilities, exact street address),

providers should contact the

appropriate landholding agencies at the

following addresses: ARMY: Mr. Jeff

Holste, CECPW–FP, U.S. Army Center

for Public Works, 7701 Telegraph Road,

Alexandria, VA 22315; (703) 428–6318;